10.1007/s00125-014-3299-4 [DOI] [PubMed] [Google Scholar] 132.Shah P, Ardestani A, Dharmadhikari G, Laue S, Schumann DM, Kerr-Conte J, et al
Through the upregulation of survival pathways and the downregulation of cell death signals, it may create conditions that support cellular persistence and function
Sn phm c kim nghim v nh gi cao bi ngi tiu dng nh vo thnh phn t nhin v cng dng h tr sc khe tng th
In addition to sleep apnea, healthcare providers were most interested in seeing GLP-1 medications approved to treat chronic heart failure and MASH (formerly NASH)
N Engl J Med 370(15):13831392 Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ et al (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial
The next horizon really is going to be cancer